Heron Therapeutics (HRTX) Change in Inventory (2016 - 2026)

Heron Therapeutics has reported Change in Inventory for 11 years, with the latest figure at $169000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 95.52% year-over-year to $169000.0; the trailing twelve-month figure through Mar 2026 stood at $27.4 million (up 89.84% YoY), and the FY2025 full-year result was $31.1 million, up 181.01% from the prior year.
• Change in Inventory for Q1 2026 stood at $169000.0, down from $14.2 million in the prior quarter.
• The five-year high for Change in Inventory was $16.0 million in Q2 2025, with the low at -$9.1 million in Q3 2022.
• Historically, Change in Inventory has averaged $2.1 million across 5 years, with a median of $391000.0 in 2024.
• Annual changes were most pronounced in 2022 — Change in Inventory tumbled 599.46% — and 2024, when it jumped 6900.0%.
• Heron Therapeutics' Change in Inventory stood at $2.3 million in 2022, then slumped by 95.59% to $103000.0 in 2023, then jumped by 6900.0% to $7.2 million in 2024, then jumped by 96.77% to $14.2 million in 2025, then tumbled by 98.81% to $169000.0 in 2026.
• The last three Change in Inventory figures came in at $169000.0 (Q1 2026), $14.2 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.